SpherIngenics

SpherIngenics is a biotechnology company that developed a proprietary microbead technology platform for the delivery and protection of cell-based therapies. Spun out of the Georgia Institute of Technology and Emory University, the company's technology utilizes hydrogel microspheres to encapsulate therapeutic cells, such as stem cells, protecting them from the host's inflammatory response and preventing migration from the injection site. This approach ensures high cell viability and localized delivery, which is critical for effective tissue regeneration and repair in applications such as bone and musculoskeletal injuries. The company has historically received funding from the Department of Defense and the Medical Technology Enterprise Consortium (MTEC) to advance its platform for treating infected wounds and bone defects. Although the company was active through 2020, it is currently considered inactive or dormant.